Session 8: Translational Aspects of HHT

10 Jun 2017
8:00 am – 9:45 am
Soderini Ballroom II, III

Session 8: Translational Aspects of HHT

Invited Speaker:  Dr. Aravind Asokan  (8:00am – 8:45am)

Towards a Gene Therapy Approach for Vascular Disorders


Oral Presentations 

8:45am – 9:00am

Evaluation of stop codon read through as a therapy for HHT

Aldred M, Sadler T, Shovlin C


9:00am – 9:15am

Mice lacking endoglin in macrophages show an impaired immune response.

Botella L, Arthur H, Bernabeu C, Ojeda-Fernández L


9:15am – 9:30am

Mosaicism involving non-blood tissue: implications for genetic testing in HHT families

McDonald J, Wooderchak-Donahue W, Paul E, Morris A, Bayrak-Toydemir P


9:30am – 9:45am

Endoglin antibody therapy produces the small vessel manifestations of HHT-1 and is associated with clinical activity when dosed with inhibitors of the VEGF pathway

Theuer C